These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11518724)

  • 1. Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding.
    Fleming RE; Sly WS
    J Clin Invest; 2001 Aug; 108(4):521-2. PubMed ID: 11518724
    [No Abstract]   [Full Text] [Related]  

  • 2. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene.
    Montosi G; Donovan A; Totaro A; Garuti C; Pignatti E; Cassanelli S; Trenor CC; Gasparini P; Andrews NC; Pietrangelo A
    J Clin Invest; 2001 Aug; 108(4):619-23. PubMed ID: 11518736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel genes, proteins, and inherited disorders of iron overload: iron metabolism is less boring than thought.
    Cazzola M
    Haematologica; 2002 Feb; 87(2):115-6. PubMed ID: 11836159
    [No Abstract]   [Full Text] [Related]  

  • 4. Iron overload: molecular clues to its cause.
    Kühn LC
    Trends Biochem Sci; 1999 May; 24(5):164-6. PubMed ID: 10322426
    [No Abstract]   [Full Text] [Related]  

  • 5. Of metals, mice, and men: what animal models can teach us about body iron loading.
    Anderson GJ; Powell LW
    J Clin Invest; 2000 May; 105(9):1185-6. PubMed ID: 10791991
    [No Abstract]   [Full Text] [Related]  

  • 6. Genes that modify the hemochromatosis phenotype in mice.
    Levy JE; Montross LK; Andrews NC
    J Clin Invest; 2000 May; 105(9):1209-16. PubMed ID: 10791995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hereditary iron overload].
    Brissot P; Bardou-Jacquet E; Latournerie M; Ropert-Bouchet M; Island ML; Loréal O; Jouanolle AM
    Pathol Biol (Paris); 2010 Oct; 58(5):316-23. PubMed ID: 19942367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal dominant hereditary hemochromatosis associated with two novel Ferroportin 1 mutations in Spain.
    Bach V; Remacha A; Altés A; Barceló MJ; Molina MA; Baiget M
    Blood Cells Mol Dis; 2006; 36(1):41-5. PubMed ID: 16257244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic haemochromatosis: genes and mutations associated with iron loading.
    Camaschella C; Roetto A; De Gobbi M
    Best Pract Res Clin Haematol; 2002 Jun; 15(2):261-76. PubMed ID: 12401307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in the study of molecular genetics of iron metabolism].
    Niitsu Y
    Nihon Naika Gakkai Zasshi; 2000 Apr; 89(4):768-73. PubMed ID: 10876938
    [No Abstract]   [Full Text] [Related]  

  • 11. [Genetic hemochromatosis and the HFE gene: from molecular genetics to clinical diagnosis].
    Höhler T; Gerken G
    Z Gastroenterol; 2000 Jun; 38(6):509-15. PubMed ID: 10923364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the DMT1 (NRAMP2/DCT1) iron transporter in mice with genetic iron overload disorders.
    Canonne-Hergaux F; Levy JE; Fleming MD; Montross LK; Andrews NC; Gros P
    Blood; 2001 Feb; 97(4):1138-40. PubMed ID: 11159549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report of a patient with non-alcoholic fatty liver disease, moderate iron overload who is homozygous for the S65C mutation in the HFE1 gene.
    Bernard PH; Ged C; Faivre E; Legac G; Bioulac-Sage P; Cassaigne A; de Verneuil H
    Eur J Med Genet; 2005; 48(2):195-8. PubMed ID: 16053912
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinicopathological study of Japanese patients with genetic iron overload syndromes.
    Hattori A; Miyajima H; Tomosugi N; Tatsumi Y; Hayashi H; Wakusawa S
    Pathol Int; 2012 Sep; 62(9):612-8. PubMed ID: 22924847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.
    Gomez PS; Parks S; Ries R; Tran TC; Gomez PF; Press RD
    Nat Genet; 1999 Nov; 23(3):272. PubMed ID: 10545944
    [No Abstract]   [Full Text] [Related]  

  • 16. SLC40A1 c.1402G-->a results in aberrant splicing, ferroportin truncation after glycine 330, and an autosomal dominant hemochromatosis phenotype.
    Lee PL; Gelbart T; West C; Barton JC
    Acta Haematol; 2007; 118(4):237-41. PubMed ID: 18160816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron-independent specific protein expression pattern in the liver of HFE-deficient mice.
    Petrak J; Myslivcova D; Halada P; Cmejla R; Cmejlova J; Vyoral D; Vulpe CD
    Int J Biochem Cell Biol; 2007; 39(5):1006-15. PubMed ID: 17376729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of hemochromatosis.
    Cullen LM; Anderson GJ; Ramm GA; Jazwinska EC; Powell LW
    Annu Rev Med; 1999; 50():87-98. PubMed ID: 10073265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis.
    Muckenthaler M; Roy CN; Custodio AO; Miñana B; deGraaf J; Montross LK; Andrews NC; Hentze MW
    Nat Genet; 2003 May; 34(1):102-7. PubMed ID: 12704390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic study of variation in normal mouse iron homeostasis reveals ceruloplasmin as an HFE-hemochromatosis modifier gene.
    Gouya L; Muzeau F; Robreau AM; Letteron P; Couchi E; Lyoumi S; Deybach JC; Puy H; Fleming R; Demant P; Beaumont C; Grandchamp B
    Gastroenterology; 2007 Feb; 132(2):679-86. PubMed ID: 17258727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.